Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its price target raised by analysts at HC Wainwright from $14.00 to $15.00. They now have a "buy" rating on the stock.
Ocular Therapeutix Inc (OCUL) Q3 2024 Earnings Call Highlights: Strong Financial Position and ... [Yahoo! Finance]
Ocular Therapeutix™ Reports Third Quarter 2024 Results and Business Highlights [Yahoo! Finance]
Ocular Therapeutix™ Reports Third Quarter 2024 Results and Business Highlights
Ocular Therapeutix™ to Present at the Jefferies London Healthcare Conference and Ophthalmology Innovation Summit XIV